title: [Experience in copaxon treatment in Russia].
authors.forename: I A
authors.initials: IA
authors.lastname: Zavalishin
authors.forename: A V
authors.initials: AV
authors.lastname: Peresedova
authors.forename: N I
authors.initials: NI
authors.lastname: Stoĭda
authors.forename: L S
authors.initials: LS
authors.lastname: Adarcheva
authors.forename: M N
authors.initials: MN
authors.lastname: Zakharova
authors.forename: A S
authors.initials: AS
authors.lastname: Niiazbekova
authors.forename: L Sh
authors.initials: LSh
authors.lastname: Askarova
authors.forename: O Iu
authors.initials: OIu
authors.lastname: Rebrova
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D000068717:Glatiramer Acetate; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D010455:Peptides / Q000008:administration & dosage / Q000627:therapeutic use*; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D010455:Peptides; D000068717:Glatiramer Acetate